Neuronetics (STIM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William Plovanic from Canaccord Genuity maintained a Buy rating on the ...

According to Benzinga Pro, Neuronetics Inc's peer group average for short interest as a percentage of float is 5.77%, which means the company has more short interest than most of its peers. This ...

Neuronetics, Inc., a medical technology company focused on mental health, has announced key updates regarding its NeuroStar therapy. The company will be a Silver Sponsor at the 13th Annual Clinical ...

Neuronetics is currently facing challenges from increased competition and a difficult macro environment, which is impacting growth and profitability. While market conditions appear to have stabilized ...

Neuronetics, Inc. has reported its financial and operating results for the fourth quarter and full year of 2024, highlighting a fourth-quarter revenue of $22.5 million, up 11% from the same period in ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Neuronetics, which has 203 ...

Fourth quarter 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as reported basis and 23% year-over-year growth on an adjusted pro forma basis Full year 2025 revenue of $149 ...

I am bullish on the niche industry that uses magnetic stimulation for brain therapies. BrainsWay and Neuronetics are US-listed stocks in this niche, however they are highly unprofitable with volatile ...

Transcranial magnetic stimulation pioneer Neuronetics has picked up a new FDA clearance that builds its position in obsessive-compulsive disorder (OCD), a major new application of the technology.

We recently compiled a list of the 10 Hot Penny Stocks to Buy Now. In this article, we are going to take a look at where Neuronetics, Inc. (NASDAQ:STIM) stands against the other hot penny stocks. On ...

MALVERN, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company ...